- Home
- ALZN vs SNTG Comparison
ALZN vs SNTG Comparison
Compare ALZN & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- SNTG
- Stock Information
- Founded
- ALZN 2016
- SNTG 2009
- Country
- ALZN United States
- SNTG China
- Employees
- ALZN N/A
- SNTG N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- SNTG Finance: Consumer Services
- Sector
- ALZN Health Care
- SNTG Finance
- Exchange
- ALZN Nasdaq
- SNTG Nasdaq
- Market Cap
- ALZN 6.1M
- SNTG 5.2M
- IPO Year
- ALZN 2021
- SNTG 2021
- Fundamental
- Price
- ALZN $0.69
- SNTG $1.87
- Analyst Decision
- ALZN Strong Buy
- SNTG
- Analyst Count
- ALZN 1
- SNTG 0
- Target Price
- ALZN $32.00
- SNTG N/A
- AVG Volume (30 Days)
- ALZN 869.9K
- SNTG 17.5K
- Earning Date
- ALZN 03-10-2025
- SNTG 04-25-2025
- Dividend Yield
- ALZN N/A
- SNTG N/A
- EPS Growth
- ALZN N/A
- SNTG N/A
- EPS
- ALZN N/A
- SNTG N/A
- Revenue
- ALZN N/A
- SNTG $146,472.00
- Revenue This Year
- ALZN N/A
- SNTG N/A
- Revenue Next Year
- ALZN N/A
- SNTG N/A
- P/E Ratio
- ALZN N/A
- SNTG N/A
- Revenue Growth
- ALZN N/A
- SNTG N/A
- 52 Week Low
- ALZN $0.66
- SNTG $1.65
- 52 Week High
- ALZN $15.06
- SNTG $3.97
- Technical
- Relative Strength Index (RSI)
- ALZN 24.21
- SNTG 50.45
- Support Level
- ALZN $0.66
- SNTG $1.75
- Resistance Level
- ALZN $0.93
- SNTG $1.93
- Average True Range (ATR)
- ALZN 0.07
- SNTG 0.09
- MACD
- ALZN -0.01
- SNTG 0.00
- Stochastic Oscillator
- ALZN 9.00
- SNTG 56.73
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.